Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (10875)
  2. Meeting Abstract (9493)
  3. Review (551)
  4. Book Section (417)
  5. Editorial (334)
  6. Guidelines (157)
  7. Correspondence (116)
  8. Conference Paper (106)
  9. Research Letter (60)
  10. Miscellaneous (54)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22168)
  2. GSK Faculty (5911)
  3. Genitourinary Oncology Service (5637)
  4. Survivorship Research (5217)
  5. Gastrointestinal Oncology Service (4673)
  6. Breast Medicine Service (4144)

More Groups

People
  1. Robert Motzer (1247)
  2. Howard Scher (1130)
  3. Clifford Hudis (905)
  4. Jedd Wolchok (905)
  5. Mark Kris (870)
  6. Leonard Saltz (791)

More People

Years
  1. 2025 (569)
  2. 2024 (1386)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5282)
  2. Annals of Oncology (1295)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (772)
  5. Journal of Thoracic Oncology (531)
  6. Gynecologic Oncology (441)

More Publications

Publishers
  1. American Society of Clinical Oncology (5573)
  2. Elsevier Inc. (2654)
  3. American Association for Cancer Research (2322)
  4. Oxford University Press (1812)
  5. Nature Publishing Group (1030)
  6. Springer (979)

More Publishers

Results (22190)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Monitoring response to immune checkpoint inhibition in patients with endometrial cancer using cell-free DNA analysis
    Meeting Abstract

    Manning-Geist, B.; Patel, J.; Marra, A.; Zammarrelli, W. A. 3rd; Da Cruz Paula, A.; Abu-Rustum, N.; Shah, R.; Berger, M.; Hensley, M.; Lakhman, Y.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Long survival in patients with adnexal high-grade serous carcinoma who underwent suboptimal cytoreductive surgery: A whole-genome analysis
    Meeting Abstract

    Sullivan, M.; Brown, D.; Paula, A. D.; Boerner, T.; O'Cearbhaill, R.; Tew, W.; Grisham, R.; Sonoda, Y.; Leitao, M.; Broach, V.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Longer-term safety and efficacy of selinexor maintenance therapy for patients with TP53WT advanced or recurrent endometrial cancer: Follow up subgroup analysis of the ENGOT-EN5/GOG-3055/SIENDO study
    Meeting Abstract

    Fidalgo, J. A. P.; Vergote, I.; Hamilton, E.; Giorgi, U. D.; Gorp, T. V.; Lübbe, K.; Zikan, M.; Helpman, L.; Miller, D. S.; Fariñas-Madrid, L.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Benefit from atezolizumab in patients with a poor prognostic ovarian cancer in first-line setting: IMAGYN-050 trial
    Meeting Abstract

    You, B.; Anderson, C.; Cecere, S. C.; Carrot, A.; Myers, T.; Heitz, F.; Sudarshan, S.; Selcukbiricik, F.; Aghajanian, C.; Fernebro, J.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • A phase 3, randomized trial evaluating avutometinib plus defactinib compared with investigator’s choice of therapy in patients with recurrent low-grade serous ovarian cancer: GOG-3097/ENGOT-ov81/NCRI/RAMP 301
    Meeting Abstract

    Grisham, R.; Monk, B.; Van Nieuwenhuysen, E.; Moore, K.; Fabbro, M.; O'Malley, D.; Oaknin, A.; Thaker, P.; Oza, A.; Colombo, N.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Randomized, phase II/III study of pegylated liposomal doxorubicin, bevacizumab, and atezolizumab in platinum-resistant ovarian cancer (NRG-GY009): Clinical outcomes by PD-L1 and T cell infiltration status
    Meeting Abstract

    O'Cearbhaill, R.; Zamarin, D.; Sill, M.; Duong, H.; Waggoner, S.; Grisham, R.; Backes, F.; Mannel, R.; Tanyi, J.; Powell, M.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib ± defactinib in recurrent low grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
    Meeting Abstract

    Banerjee, S.; Aghajanian, C.; Van Nieuwenhuysen, E.; Santin, A.; Ring, K.; Colombo, N.; Thaker, P.; Prendergast, E.; Moore, K.; Chon, H. S.; more...
    International Journal of Gynecological Cancer (2024)

    Fulltext@MSK | Save
  • Characterising the contribution of rare protein-coding variants to prostate cancer risk and severity in 36,866 cases
    Meeting Abstract

    Mitchell, J.; Camacho, N.; Shea, P. R.; Stopsack, K.; Joseph, V.; Burren, O.; Penney, K.; Berchuck, J.; Wang, Q. L.; Goldstein, D.; more...
    European Journal of Human Genetics (2024)

    Fulltext@MSK | Save
  • Clinical outcomes of patients with metastatic urothelial carcinoma (mUC) discontinuing enfortumab vedotin (EV) monotherapy (mono) without disease progression
    Meeting Abstract

    Sternschuss, M.; Whiting, K.; Teo, M. Y.; Bajorin, D.; Kotecha, R.; Laccetti, A. L.; Xiao, H.; Feld, E.; McHugh, D. J.; Keegan, N.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save
  • Alliance A031501: AMBASSADOR study of adjuvant pembrolizumab (Pembro) in muscle-invasive urothelial carcinoma (MIUC) vs observation (Obs): Extended follow-up disease-free survival (DFS) results and metastatic (met) disease recurrence distribution
    Meeting Abstract

    Apolo, A. B.; Ballman, K.; Sonpavde, G. P.; Berg, S.; Kim, W.; Parikh, R.; Teo, M. Y.; Sweis, R. F.; Geynisman, D.; Grivas, P.; more...
    Annals of Oncology (2024)

    Fulltext@MSK | Save